Dergiler / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 3

Renal artery stenosis and mean platelet volume

Sayfa
197–201
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Considering both the effect of platelets on atherosclerosis and their close association with other risk factors, MPV level may be an important factor in pathogenesis of ARAS.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Increased mean platelet volume (MPV) has been reported in various atherosclerotic diseases.
📊
Temel Bulgular & Veri:The aim of our study was to investigate the relationship between the atherosclerotic renal artery stenosis (ARAS) and various hematological parameters including MPV.Methods: This study was performed with a retrospective review of the angiographic images of patients who underwent renal angiography at Bülent Ecevit University catheter laboratory between January 2004 and December 2009.
💡
Sonuç & Katkı:Considering both the effect of platelets on atherosclerosis and their close association with other risk factors, MPV level may be an important factor in pathogenesis of ARAS.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2004 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Increased mean platelet volume (MPV) has been reported in various atherosclerotic diseases. The aim of our study was to investigate the relationship between the atherosclerotic renal artery stenosis (ARAS) and various hematological parameters including MPV.Methods: This study was performed with a retrospective review of the angiographic images of patients who underwent renal angiography at Bülent Ecevit University catheter laboratory between January 2004 and December 2009. The patients were trichotomized into three groups based on the presence and severity of renal artery stenosis (RAS). Group 1 included patients with a critical RAS (33 patients; 18 female (F), 15 male (M); mean age 61.6±11.5 years), group 2 consisted of patients with non-critical RAS (26 patients; 15 F, 11 M; mean age 58.1±11.3 years), and group 3 was composed of patients without RAS (69 patients; 38 F, 31 M; mean age 53.5±11.9 years). Demographic data, complete blood count, and biochemical parameters were compared between the groups.Results: Comparison of the hematological parameters revealed that MPV and platelet distribution width were significantly higher in group 1 than in group 2 and 3 (8.96±0.99 fL versus 8.35±0.76 fL, 8.31±0.79 fL, respectively; p=0.001; 16.53±0.58% versus 16.19±0.56%, 16.29±0.53%, respectively; p=0.04).Conclusion: MPV levels are higher in patients with ARAS. Considering both the effect of platelets on atherosclerosis and their close association with other risk factors, MPV level may be an important factor in pathogenesis of ARAS.

🔖

Bu Makaleye Atıf Yap

SAYIN, M. R., YAVUZ, N., KARABAĞ, T., ÇETİNER, M. A., ÖZ, İ. İ., GÜNGÖRDÜK, O. A., AYDIN, M. (2016). Renal artery stenosis and mean platelet volume. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 3, 197–201. https://ajindex.com/articles/365475

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Boateng FK, Greco BA. Renal Artery Stenosis: prevalence of, risk factors for, and management of in-stent stenosis. Am J Kidney Dis 2013; 61: 147-60.
  2. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002; 36: 443-51.
  3. Rimmer JM, Gennari FJ. Atherosclerotic renal vascular disease and progressive renal failure. Ann Intern Med 1993; 118: 712-9.
  4. Colyer WR, Eltahawy E, Cooper CJ. Renal artery stenosis: optimiz- ing diagnosis and treatment. Prog Cardiovasc Dis 2011; 4: 29-35. Scoble JE, de Takats D, Ostermann ME, Connolly JO, Scott NR, Beeso JA, et al. Lipid profiles in patients with atherosclerotic renal artery stenosis. Nephron 1999; 83: 117-21.
  5. Dzielinska Z, Januszewicz A, Demkow M, Makowiecka-Ciesla M, Prejbisz A, Naruszewicz M, et al. Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J Hypertens 2007; 25: 663-70.
  6. Gawaz M, Langer H, May AE. Platelets in inflammation and athero- genesis. J Clin Invest 2005; 115: 3378-84. Lancé MD, Sloep M, Henskens YM, Marcus MA. Mean platelet volume as a diagnostic marker for cardiovascular disease: draw- backs of preanalytical conditions and measuring techniques. Clin Appl Thromb Hemost 2012; 18: 561-8.
  7. Fateh-Moghadam S, Li Z, Ersel S, Reuter T, Htun P, Plöckinger U, et al. Platelet degranulation is associated with progression of intima- media thickness of the common carotid artery in patients with diabetes mellitus type 2. Arterioscler Thromb Vasc Biol 2005; 25: 1299-303.
  8. Fateh-Moghadam S, Bocksch W, Ruf A, Dickfeld T, Schartl M, Pogátsa-Murray G, et al. Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vas- culopathy. Circulation 2000; 102: 890-7.
  9. Willoughby S, Holmes A, Loscalzo J. Platelets and cardiovascular disease. Eur J Cardiovasc Nurs 2002; 1: 273-88.
  10. Nurkalem Z, Alper AT, Orhan AL, Zencirci AE, Sarı I, Erer B, et al. Mean platelet volume in patients with slow coronary flow and its relationship with clinical presentation. Turk Kardiyol Dern Ars 2008; 36: 363-7.
  11. Dubel GJ, Murphy TP. The role of percutaneous revascularization for renal artery stenosis. Vasc Med 2008; 13: 141-56.
  12. Kaatee R, Beek FJ, Verschuyl EJ, Ven PJ, Beutler JJ, van Schaik JP, et al. Atherosclerotic renal artery stenosis: ostial or truncal? Radiology 1996; 199: 637-40.
  13. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of